Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15952055

Download in:

View as

General Info

PMID
15952055